Clinical Trials Logo
  1. Home
  2. Breast Cancer
  3. NCT05995483
  4. Details
NCT05995483 Clinical Trial

Experimental Study With Pretest/Posttest Groups Which the Intervention Group Have the System Which Sends Reminder Notifications Directing Them to the Website Containing BSE Training Along With the Illustrations Created for the Practice Prepared by the Researcher on the Determined Ideal Day

Breast Cancer Clinical Trial

— BreastSelfExam  

Official title:
Kendi Kendine Meme Muayenesi Ile İlgili Anımsatıcı Bildirimlerin Meme Kanseri Korkusu ve Sağlık İnançları Üzerine Etkisi/The Effect of Reminder Notifications About Breast Self-Exam on Fear of Breast Cancer and Health Beliefs

Clinical Trial Details — Status: Active, not recruiting

Administrative data
NCT number NCT05995483
Other study ID # ETK00-2022-0030
Secondary ID
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date April 4, 2023
Est. completion date September 4, 2023

Study information
Verified date August 2023
Source Eastern Mediterranean University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

H0: Among the intervention and control groups of reminder notifications relating to self-examination H01: Average breast cancer fear score and H02: There is no difference in the average score of breast cancer health beliefs. H1: Among the intervention and control groups of reminder notifications relating to self-examination H11: Average breast cancer fear score H12: Breast cancer is different in terms of average score of health beliefs

Description:

Newly Enrolled Students in the Nursing Programs at Girne American University and Eastern Mediterranean University Will Participate in This Study as an Experimental Study With a Pretest/Posttest Control Group. The Students Will Receive the Same Training. Contrary to the Control Group, the Intervention Group Will Have the System Which Will Send Reminder Notifications (Via the Web Base) Directing Them to the Website Containing BSE Training, Along With the Vector Illustration to be Created for the Concurrent Practice Prepared by the Researcher on the Determined Ideal Day. Users Will Receive a Notification Twice Via the Website and Email That Includes Re-examination Seven Days Following the End of Their Period. Depending on the Permission They Grant to Their Phones, Users Will be Able to Access the BSE Training Materials on the Website by Clicking on the General Reminder Notification or the Router, Using Their Browsers, and Logging in to Their Accounts. The Data on the Frequency of BSE With the "Breast Cancer Fear Scale" and "Champion's Health Belief Model Scale" Will be Collected From the Users at the End of the Three-month Period of Using the Website, Which Will be Developed in Order to Raise the Chances of Early Diagnosis by Encouraging BSE.

Recruitment information / eligibility
Status Active, not recruiting
Enrollment 76
Est. completion date September 4, 2023
Est. primary completion date September 4, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years to 30 Years
Eligibility Inclusion Criteria: - Who is over 18 years old, - Eastern Mediterranean University and Girne American University, newly enrolled female students in the Nursing Department of the Faculty of Health Sciences Exclusion Criteria: - People who do not meet the criteria

Study Design

Related Conditions & MeSH terms

Intervention

Other:
• Early Diagnosis on BSE
the System Which Sends Reminder Notifications Directing Them to the Website Containing BSE Training Along With the Illustrations Created for the Practice Prepared by the Researcher on the Determined Ideal Day.

Locations
Country Name City State
Cyprus Eastern Mediterranean University & Girne American University Kyrenia

Sponsors (1)
Lead Sponsor Collaborator
Eastern Mediterranean University

Country where clinical trial is conducted

Cyprus, 

Outcome
Type Measure Description Time frame Safety issue
Primary Change in the health belief scores on 'Champion Health Belief Model Scale' and 'Breast Cancer Fear Scale' related web based BSE examination notifications in 3 months. Measuring the health belief on breast cancer early diagnosis and awareness with web based bse training and notifications using 'Champion Health Belief Model Scale' and 'Breast Cancer Fear Scale'. 3 months
See also
  Status Clinical Trial Phase
Recruiting NCT04681911 - Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer Phase 2
Terminated NCT04066790 - Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer Phase 2
Completed NCT04890327 - Web-based Family History Tool N/A
Completed NCT03591848 - Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of Fertility N/A
Recruiting NCT03954197 - Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients N/A
Terminated NCT02202746 - A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer Phase 2
Active, not recruiting NCT01472094 - The Hurria Older PatiEnts (HOPE) With Breast Cancer Study
Recruiting NCT06049446 - Combining CEM and Magnetic Seed Localization of Non-Palpable Breast Tumors
Withdrawn NCT06057636 - Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study N/A
Recruiting NCT05560334 - A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations Phase 2
Active, not recruiting NCT05501769 - ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer Phase 1
Recruiting NCT04631835 - Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer Phase 1
Completed NCT04307407 - Exercise in Breast Cancer Survivors N/A
Recruiting NCT03544762 - Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation Phase 3
Terminated NCT02482389 - Study of Preoperative Boost Radiotherapy N/A
Enrolling by invitation NCT00068003 - Harvesting Cells for Experimental Cancer Treatments
Completed NCT00226967 - Stress, Diurnal Cortisol, and Breast Cancer Survival
Recruiting NCT06006390 - CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors Phase 1/Phase 2
Recruiting NCT06019325 - Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy N/A
Recruiting NCT06037954 - A Study of Mental Health Care in People With Cancer N/A